|
|
Article: The University of Cambridge, Cancer Research Technology, Cancer Research UK and Perlegen Sciences Collaborate to Analyze Thousands of DNA Samples from Breast Cancer Patients.
- Article from:
- Business Wire
- Article date:
- February 16, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MOUNTAIN VIEW, Calif. & CAMBRIDGE, England & LONDON -- Massive 200 Million Genotype Study Will Search Across Entire Genome for Genetic Causes of Breast Cancer
The University of Cambridge, Cancer Research Technology, Cancer Research UK and Perlegen Sciences, Inc. (Nasdaq:AFFX) announced today that they will be collaborating to conduct a high-resolution, whole genome association study on breast cancer. Scientists will determine over 200 million individual genotypes in DNA samples collected from patients to further elucidate the genetic basis of the disease with which over one million individuals worldwide are diagnosed annually.
The study's initial results ...